May 19, 2020
VSMS ECG Patch receives US FDA 'Emergency Use Authorisation' for patients being treated for COVID-19
Apr 22, 2020
Cardiologs Announces Clinical Study to Monitor Cardiac Safety of COVID-19 Patients Via Smartwatches
Apr 21, 2020
Niche Pharmaceuticals Recommends Use of Its Mag-Tab®SR to Help Offset Cardiac Issues
Apr 13, 2020
AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients
Apr 07, 2020
FDA Allows Expanded Use of Remote Devices to Monitor Patients' Vital Signs in Global COVID-19 Health Crisis
Mar 26, 2020
The Cardiac Risk of Chloroquine in Unapproved Indications
Mar 23, 2020
New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients
Mar 10, 2020
AltaThera Pharmaceuticals Announces FDA Approval for New Indications of Sotalol IV: A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients
Nov 19, 2019
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
Jul 22, 2019
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
Apr 26, 2019
QTC Care Closes 7 million USD Series-A Financing - Focusing on Introducing Global Top Medical Resources to China and Advancing Health Management Platforms
Apr 02, 2019
The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science | ACCP/CSRC Position Paper
May 10, 2018
Previously Invisible Long QT Syndrome Now Observable With Machine Learning
Oct 25, 2017
Neurocrine Initiates Phase IIb Clinical Study of Once-daily INGREZZA® in Children and Adolescents with Tourette Syndrome
Oct 23, 2017
Neurocrine Granted FDA Orphan Drug Designation for Valbenazine for the Treatment of Pediatric Patients With Tourette Syndrome